29 Trending Stocks

Wed, Jan 20, 2021

Catalyst Pharmaceuticals Inc

CPRX 3.69
0.11 (3.1%)

Open: 3.58 High: 3.79 Low: 3.55

9 x 3.69 = 33.21
x $3.69 =

NASDAQ: CPRX $360 Million Small-Cap. Health Care Sector. Drug Manufacturers Industry. 5 Year Return 76%. 1 Year Return 10%. 2021 YTD Return 5%. Since Earnings 17%.

ST

External Links

Charts

image
image

52WL $2.61

The 52 Week Low is $2.61 set on Mon, Mar 16, 2020.

52WH $5.27

The 52 Week High is $5.27 set on Fri, Feb 21, 2020.

ATH $7.67

The All-Time High is $7.67 set on Wed, Sep 11, 2019.

52 Week Range

$2.61
$5.27
Mar 16, 2020
Feb 21, 2020

Earnings

0.09

Earnings Per Share

0.00

Price To Earnings Ratio


Q2 Earnings for Apr, May & Jun

Mon, Aug 10, 2020

Since Q2 Earnings Report

CPRX 8.9%


Q3 Earnings for Jul, Aug & Sep

Mon, Nov 9, 2020

Since Q3 Earnings Report

CPRX 17.1%

Dividends

0.00

Dividend Yield

0.00

Dividend Rate

--

Ex-Dividend Date

--

Dividend Payment Date

--

Dividend Frequency

0

Dividend History

Profile

Catalyst Pharmaceuticals Inc trades on the NASDAQ. CPRX's market cap is 360.00 Million.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome.

Website

Related Channels

Free Channels & more...

For Starters

Account Channels

Track your portfolio and more.